| Lansoprazole (sodiuM) |
兰索拉唑钠 |
226904-00-3 |
| LB 42708 |
2MG |
226929-39-1 |
| methyl 4-(2-bromoethynyl)benzoate |
4-(2-溴乙炔)苯甲酸甲酯 |
225928-10-9 |
| Cathepsin Inhibitor 1 |
Cathepsin Inhibitor 1 |
225120-65-0 |
| OMALIZUMAB |
奥马珠单抗 |
242138-07-4 |
| 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER |
4-(4-氟苯基)-3-氧代丁酸乙酯 |
221121-37-5 |
| Selamectin |
塞拉菌素 |
220119-17-5 |
| Tulathromycin A |
托拉菌素 A |
217500-96-4 |
| Quinolinium, 4-[3-(3-methyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-1-octyl-, 1,1,1-trifluoromethanesulfonate |
4-[3-(3-甲基-2(3H)-苯并噻唑亚基)-1-丙烯-1-基]-1-辛基喹啉三氟甲磺酸盐 |
218300-22-2 |
| 3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate |
化合物3-(3-BROMO-2-THIENYL)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-2-ENE FUMARATE |
216853-60-0 |
| Cochinchinenin A |
剑叶龙血素A |
221696-69-1 |
| PD 166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐 |
212391-63-4 |
| Eculizumab |
托西珠单抗 |
219685-50-4 |
| Cy5.5 |
荧光染料 |
210892-23-2 |
| AT-130
(AT130) |
AT-130
(AT130) |
211364-06-6 |
| SU5402 |
2-[(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-4-甲基-1H-吡咯-3-丙酸 |
215543-92-3 |
| Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-piperidinyl)-2-pyridinyl]amino]- |
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-piperidinyl)-2-pyridinyl]amino]- |
1637781-04-4 |
| STING-Inducer-1 |
1638241-89-0 |
1638241-89-0 |
| R-Avanafil |
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羟甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺 |
1638497-26-3 |
| Hydronidone |
Hydronidone |
1631754-41-0 |
QQ
微信
